Hospital beds are undergoing an upgrade to become a source of data

Hospital beds may soon be able to transfer information about patients, as one major manufacturer in the space is giving the medical equipment a major upgrade, The Wall Street Journal reported.

The transition will enable beds to sensor a patient’s vital signs 100 times per minute, and signals that hospitals are fully in the midst of a digital transformation.

Hill-Rom Holdings, a medical equipment manufacturer, is the company behind the upgrades, which can alert nurses when vital signs suggest deterioration in a patient’s condition. Other medical device companies are following suit.

At one time, hospitals were falling behind in the digital awakening, but years of playing catch-up by installing electronic medical records and internet-connected devices has led to a breakthrough––more than 80 percent of hospitals use EHRs, according to the American Hospital Association. By comparison, hospitals have come a long way from the 9.4 percent use rate in 2008.

The digital push is good news for vendors in the space, too, which see many opportunities to cash in.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.